Literature DB >> 8397790

Large scale purification and refolding of HIV-1 protease from Escherichia coli inclusion bodies.

J O Hui1, A G Tomasselli, I M Reardon, J M Lull, D P Brunner, C S Tomich, R L Heinrikson.   

Abstract

The protease encoded by the human immunodeficiency virus type 1 (HIV-1) was engineered in Escherichia coli as a construct in which the natural 99-residue polypeptide was preceded by an NH2-terminal methionine initiator. Inclusion bodies harboring the recombinant HIV-1 protease were dissolved in 50% acetic acid and the solution was subjected to gel filtration on a column of Sephadex G-75. The protein, eluted in the second of two peaks, migrated in SDS-PAGE as a single sharp band of M(r) approximately 10,000. The purified HIV-1 protease was refolded into an active enzyme by diluting a solution of the protein in 50% acetic acid with 25 volumes of buffer at pH 5.5. This method of purification, which has also been applied to the purification of HIV-2 protease, provides a single-step procedure to produce 100 mg quantities of fully active enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397790     DOI: 10.1007/bf01028194

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  11 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virus protease.

Authors:  T D Copeland; S Oroszlan
Journal:  Gene Anal Tech       Date:  1988 Nov-Dec

3.  An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.

Authors:  P Ashorn; T J McQuade; S Thaisrivongs; A G Tomasselli; W G Tarpley; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease.

Authors:  R F Nutt; S F Brady; P L Darke; T M Ciccarone; C D Colton; E M Nutt; J A Rodkey; C D Bennett; L H Waxman; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.

Authors:  A G Tomasselli; M K Olsen; J O Hui; D J Staples; T K Sawyer; R L Heinrikson; C S Tomich
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

6.  Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.

Authors:  S Thaisrivongs; A G Tomasselli; J B Moon; J Hui; T J McQuade; S R Turner; J W Strohbach; W J Howe; W G Tarpley; R L Heinrikson
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

7.  Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease.

Authors:  J Schneider; S B Kent
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

8.  Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.

Authors:  N Thanki; J K Rao; S I Foundling; W J Howe; J B Moon; J O Hui; A G Tomasselli; R L Heinrikson; S Thaisrivongs; A Wlodawer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

9.  Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein.

Authors:  S Pichuantes; L M Babé; P J Barr; C S Craik
Journal:  Proteins       Date:  1989

10.  Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.

Authors:  J E Strickler; J Gorniak; B Dayton; T Meek; M Moore; V Magaard; J Malinowski; C Debouck
Journal:  Proteins       Date:  1989
View more
  21 in total

1.  Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease.

Authors:  Nancy M King; Laurence Melnick; Moses Prabu-Jeyabalan; Ellen A Nalivaika; Shiow-Shong Yang; Yun Gao; Xiaoyi Nie; Charles Zepp; Donald L Heefner; Celia A Schiffer
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

2.  Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.

Authors:  Oscar Alvizo; Seema Mittal; Stephen L Mayo; Celia A Schiffer
Journal:  Protein Sci       Date:  2012-06-05       Impact factor: 6.725

3.  Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.

Authors:  Michael D Altman; Ellen A Nalivaika; Moses Prabu-Jeyabalan; Celia A Schiffer; Bruce Tidor
Journal:  Proteins       Date:  2008-02-15

4.  Crystallization and preliminary neutron diffraction studies of HIV-1 protease cocrystallized with inhibitor KNI-272.

Authors:  Hiroyoshi Matsumura; Motoyasu Adachi; Shigeru Sugiyama; Shino Okada; Megumi Yamakami; Taro Tamada; Koushi Hidaka; Yoshio Hayashi; Tooru Kimura; Yoshiaki Kiso; Tomoya Kitatani; Sho Maki; Hiroshi Y Yoshikawa; Hiroaki Adachi; Kazufumi Takano; Satoshi Murakami; Tsuyoshi Inoue; Ryota Kuroki; Yusuke Mori
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-25

5.  Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.

Authors:  Mina Henes; Gordon J Lockbaum; Klajdi Kosovrasti; Florian Leidner; Gily S Nachum; Ellen A Nalivaika; Sook-Kyung Lee; Ean Spielvogel; Shuntai Zhou; Ronald Swanstrom; Daniel N A Bolon; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  ACS Chem Biol       Date:  2019-08-13       Impact factor: 5.100

6.  Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.

Authors:  Jennifer E Foulkes; Moses Prabu-Jeyabalan; Deyna Cooper; Gavin J Henderson; Janera Harris; Ronald Swanstrom; Celia A Schiffer
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  HIV-I protease. Cloning, expression, and purification.

Authors:  N I Dergousova; A M Volynskaya; L D Rumsh
Journal:  Appl Biochem Biotechnol       Date:  1996 Oct-Nov       Impact factor: 2.926

8.  Structural and kinetic analyses of the protease from an amprenavir-resistant human immunodeficiency virus type 1 mutant rendered resistant to saquinavir and resensitized to amprenavir.

Authors:  W Markland; B G Rao; J D Parsons; J Black; L Zuchowski; M Tisdale; R Tung
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Modulation of HIV protease flexibility by the T80N mutation.

Authors:  Hao Zhou; Shangyang Li; John Badger; Ellen Nalivaika; Yufeng Cai; Jennifer Foulkes-Murzycki; Celia Schiffer; Lee Makowski
Journal:  Proteins       Date:  2015-09-29

10.  Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.

Authors:  Jennifer E Foulkes-Murzycki; Christina Rosi; Nese Kurt Yilmaz; Robert W Shafer; Celia A Schiffer
Journal:  ACS Chem Biol       Date:  2012-12-27       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.